Weight-loss drugs that mimic glucagon-like peptide-1 (GLP-1) may help prevent further tissue damage after a heart attack, significantly lowering the risk of life-threatening complications that affect up to half of patients, according to a new study led by researchers at the University of Bristol and University College London (UCL)
I highly recommend Karla, she always takes time with me and truly cares.Jennifer WorleyEmily has been amazing
Sonia Hernndez-Daz, professor of epidemiology, was a co-author
Now, social media users are claiming the blockbuster medications may have another surprising perk: easing symptoms of ADHD
Gastrointestinal issues dominate, including nausea (44-50 percent of patients), vomiting (24-31 percent), diarrhea (30-40 percent), constipation (24-30 percent), and abdominal pain (20-25 percent)
Both medications are administered via injection and are effective in treating type 2 diabetes and obesity